Omnia Family Wealth’s Meridian Bioscience Inc VIVO Stock Holding History

Omnia Family Wealth’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-143	Closed	-$3K	–	556
2019 Q1	$3K	Hold	143	–	–	﹤0.01%	427
2018 Q4	$2K	Hold	143	–	–	﹤0.01%	464
2018 Q3	$2K	Hold	143	–	–	﹤0.01%	505
2018 Q2	$2K	Hold	143	–	–	﹤0.01%	486
2018 Q1	$2K	Hold	143	–	–	﹤0.01%	503
2017 Q4	$2K	Hold	143	–	–	﹤0.01%	521
2017 Q3	$2K	Hold	143	–	–	﹤0.01%	524
2017 Q2	$2K	Hold	143	–	–	﹤0.01%	629
2017 Q1	$2K	Sell	143 -32	-18%	-$447	﹤0.01%	630
2016 Q4	$3K	Buy	+175	New	+$3.07K	﹤0.01%	549

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Omnia Family Wealth's VIVO Position: Q2 2019 in Review

Omnia Family Wealth sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 143 shares — an estimated $3K sold.

Omnia Family Wealth first reported a position in VIVO in Q4 2016 and held it in 10 quarters. The position peaked at $3K in Q1 2019. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Omnia Family Wealth reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Omnia Family Wealth sold 143 Meridian Bioscience Inc shares in Q2 2019, an estimated $3K.
Omnia Family Wealth first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 10 quarters.
Omnia Family Wealth's Meridian Bioscience Inc position peaked at $3K in Q1 2019.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.